# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Calidi and SIGA are partnering in order to advance Calidi's RTNova virotherapy for lung cancer and metastatic solid tumors.
Calidi Biotherapeutics, Inc. (NYSE:CLDI), a clinical-stage biotechnology company developing a new generation of targeted antitu...
SIGA Technologies (NASDAQ:SIGA) reported quarterly earnings of $0.14 per share. This is a 1500 percent increase over losses of ...
https://www.the-sun.com/health/11114810/mutant-monkeypox-mpox-pandemic-potential/